Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Patent Analysis
- Analysis of Porter’s Five Forces
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
- Future Perspective
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Prevalence of Cancer Cases Globally
- Rise in Government Funding and Pharmaceutical R&D Spending
- Nanoparticles in Cancer Treatment: Advantages
- Precision Targeting of Cancer Cells with Nanomaterials
- Market Restraints
- Roadblocks to Clinical Nanoparticle Use
- Lack of Oncology Professionals
- Market Opportunities
- Mechanism of Nanoparticles in Overcoming Drug Resistance
- Cancer Proteomics
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and New Developments
- Emerging Trends and Technologies
- Artificial Intelligence
- Quantum Dots
- Oncology Products Pipeline
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Market Analysis by Product Type
- Global Market Size and Forecast
- Liposomes
- Polymeric Nanoparticles
- Micelles
- Hydrogels
- Dendrimers
- Market Analysis by Cancer Type
- Global Market Size and Forecast
- Lung Cancer
- Breast Cancer
- Leukemia
- Lymphoma
- Melanoma
- Other Cancers
- Geographic Breakdown
- Market Analysis by Region
- Global Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Chapter 7 Competitive Intelligence
- Overview
- Competitive Landscape
List of Tables
Summary Table: Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 1: Select Patent Grants on Nanotechnology in Cancer Treatment, 2024 and 2025
Table 2: Porter’s Five Forces Analysis: Nanotechnology in Cancer Treatment Market
Table 3: Selected Clinical Trials Studies on Nanotechnology in Cancer Treatment, 2024
Table 4: Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 5: Global Market for Nanotechnology-based Liposomes in Cancer Treatment, by Region, Through 2029
Table 6: Global Market for Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, Through 2029
Table 7: Global Market for Nanotechnology-based Micelles in Cancer Treatment, by Region, Through 2029
Table 8: Global Market for Nanotechnology-based Hydrogels in Cancer Treatment, by Region, Through 2029
Table 9: Global Market for Nanotechnology-based Dendrimers in Cancer Treatment, by Region, Through 2029
Table 10: Global Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 11: Global Market for Nanotechnology in Lung Cancer Treatment, by Region, Through 2029
Table 12: Global Market for Nanotechnology in Breast Cancer Treatment, by Region, Through 2029
Table 13: Global Market for Nanotechnology in Leukemia Cancer Treatment, by Region, Through 2029
Table 14: Global Market for Nanotechnology in Lymphoma, by Region, Through 2029
Table 15: Global Market for Nanotechnology in Melanoma Treatment, by Region, Through 2029
Table 16: Global Market for Nanotechnology in Other Cancers, by Region, Through 2029
Table 17: Global Market for Nanotechnology in Cancer Treatment, by Region, Through 2029
Table 18: North American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 19: North American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 20: North American Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 21: European Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 22: European Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 23: European Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 24: Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 25: Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 26: Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 27: Middle East and African Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 28: Middle East and African Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 29: South American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 30: South American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 31: Major Market Players in Nanotechnology in Cancer Treatment, 2023
Table 32: Abbreviations Used in this Report
Table 33: Information Sources in this Report
Table 34: AstraZeneca: Company Snapshot
Table 35: AstraZeneca: Financial Performance, FY 2022 and 2023
Table 36: AstraZeneca: Product Portfolio
Table 37: AstraZeneca: News/Key Developments, 2023 and 2024
Table 38: Baxter: Company Snapshot
Table 39: Baxter: Financial Performance, FY 2022 and 2023
Table 40: Baxter: Product Portfolio
Table 41: Baxter: News/Key Developments, 2021
Table 42: Boston Scientific Corp.: Company Snapshot
Table 43: Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 44: Boston Scientific Corp.: Product Portfolio
Table 45: Boston Scientific Corp.: News/Key Developments, 2021
Table 46: Bristol-Myers Squibb Co.: Company Snapshot
Table 47: Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 48: Bristol-Myers Squibb Co.: Product Portfolio
Table 49: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 50: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 51: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 52: Jazz Pharmaceuticals Inc.: Company Snapshot
Table 53: Jazz Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 54: Jazz Pharmaceuticals Inc.: Product Portfolio
Table 55: Les Laboratoires Servier: Company Snapshot
Table 56: Les Laboratoires Servier: Financial Performance, FY 2022 and 2023
Table 57: Les Laboratoires Servier: Product Portfolio
Table 58: Les Laboratoires Servier: News/Key Developments, 2023 and 2024
Table 59: Novartis AG: Company Snapshot
Table 60: Novartis AG: Financial Performance, FY 2022 and 2023
Table 61: Novartis AG: Product Portfolio
Table 62: Pfizer Inc.: Company Snapshot
Table 63: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 64: Pfizer Inc.: Product Portfolio
Table 65: Pfizer Inc.: News/Key Developments, 2023
Table 66: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 67: Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 68: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 69: Few Emerging Players in Nanotechnology in Cancer Treatment Market
List of Figures
Summary Figure: Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 1: Market Dynamics of Nanotechnology in Cancer Treatment
Figure 2: Breakdown of Most Frequent Cancers in Women, by Type, 2022
Figure 3: Breakdown of Most Frequent Cancers in Men, by Type, 2022
Figure 4: Estimated Cancer Incidence and Mortality Cases Globally, by Cancer Type, 2024
Figure 5: Trends in NCI Funding for Cancer Research, by Year, 2012-2019
Figure 6: Global Pharmaceutical R&D Spending, 2020-2026
Figure 7: Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 8: Global Market Shares of Nanotechnology-based Liposomes in Cancer Treatment, by Region, 2023
Figure 9: Global Market Shares of Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, 2023
Figure 10: Global Market Shares of Nanotechnology-based Micelles in Cancer Treatment, by Region, 2023
Figure 11: Global Market Shares of Nanotechnology-based Hydrogels in Cancer Treatment, by Region, 2023
Figure 12: Global Market Shares of Nanotechnology-based Dendrimers in Cancer Treatment, by Region, 2023
Figure 13: Global Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 14: Global Market Shares of Nanotechnology in Lung Cancer Treatment, by Region, 2023
Figure 15: Global Market Shares of Nanotechnology in Breast Cancer Treatment, by Region, 2023
Figure 16: Global Market Shares of Nanotechnology in Leukemia Cancer Treatment, by Region, 2023
Figure 17: Global Market Shares of Nanotechnology in Lymphoma, by Region, 2023
Figure 18: Global Market Shares of Nanotechnology in Melanoma Treatment, by Region, 2023
Figure 19: Global Market Shares of Nanotechnology in Other Cancers, by Region, 2023
Figure 20: Global Market Shares of Nanotechnology in Cancer Treatment, by Region, 2023
Figure 21: North American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 22: North American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 23: North American Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 24: European Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 25: European Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 26: European Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 27: Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 28: Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 29: Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 30: Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 31: Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 32: South American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 33: South American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 34: AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 35: AstraZeneca: Revenue Share, by Country/Region, FY 2023
Figure 36: Baxter: Revenue Share, by Business Unit, FY 2023
Figure 37: Baxter: Revenue Share, by Country/Region, FY 2023
Figure 38: Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39: Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40: Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 41: Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 42: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 43: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 44: Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 45: Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 46: Les Laboratoires Servier: Revenue Share, by Business Unit, FY 2023
Figure 47: Les Laboratoires Servier: Revenue Share, by Region, FY 2023
Figure 48: Novartis AG: Revenue Share, by Business Unit, FY 2023
Figure 49: Novartis AG: Revenue Share, by Country/Region, FY 2023
Figure 50: Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 51: Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 52: Teva Pharmaceutical Industries Ltd.: Market Share, by Business Unit, FY 2023
Figure 53: Teva Pharmaceutical Industries Ltd.: Market Share, by Region, FY 2023
